Manager TitleAgeSince
Director of Finance/CFO - 2024-12-31
President - -
Chief Tech/Sci/R&D Officer - 2024-12-31
Director TitleAgeSince
Director/Board Member - 2022-12-21
Director/Board Member - 2022-12-21
Director/Board Member - 2022-12-21
Date Insider Type Main position Quantity % Market Cap. Importance
12/22/22 Free

Director

9,285 0.0206%
12/22/22 Issuer sale

Director

6,357 0.0141%
12/22/22 Issuer sale

Chief Executive Officer

917,560 2.0349%
Change 5-day change 1-year change 3-year change Capi.($)
+0.06%+0.23% - - 17.19B
-2.79%-4.38%+16.90%+42.75% 248B
-3.16%-5.43%-0.82%+4.42% 155B
-2.01%-10.04%-27.74%+28.17% 138B
-2.35%-5.32%-56.54%-22.92% 60.85B
-1.95%-4.95%+21.12%+51.59% 58.56B
-1.96%-2.25%+4.04%-14.08% 52.46B
-2.83%-2.06%+17.45%+49.48% 48.04B
-3.51%-4.30%+16.33%+68.80% 43.29B
+1.26%-11.71%-1.58%+48.97% 43.1B
Average -1.92%-4.22%-1.20%+28.58% 94B
Weighted average by Cap. -2.37%-3.87%-0.34%+27.77%
Logo Abiomed, Inc.
Abiomed, Inc. specializes in the development, manufacturing and marketing of medical devices to assist or replace the pumping function of the failing heart. Net sales break down by activity as follows: - sale of products (95.4%): heart pumps (Impella brand); - sale of services (4.6%): including preventive maintenance services. Net sales are distributed geographically as follows: the United States (81.2%), Europe (12.8%), Japan (5%) and other (1%).
Employees
2,003
  1. Stock Market
  2. Stocks
  3. ABMD Stock